Workup and Treatment for Hypogonadism
The cornerstone of diagnosing hypogonadism requires the presence of specific signs and symptoms combined with laboratory confirmation of decreased morning total testosterone levels measured on at least two separate occasions, with levels below 300 ng/dL confirming the diagnosis. 1, 2
Diagnostic Workup
Clinical Assessment
- Sexual symptoms: Reduced libido, erectile dysfunction, decreased spontaneous/morning erections 2
- Physical symptoms: Decreased energy, decreased physical strength/activity, fatigue 2
- Psychological symptoms: Low mood, decreased motivation, concentration difficulties 2
Laboratory Testing
Initial hormone panel:
- Morning total testosterone (measure at least twice, preferably before 10 AM)
- Luteinizing hormone (LH)
- Follicle-stimulating hormone (FSH) 2
Additional baseline measurements:
- Hemoglobin/hematocrit
- Prostate-specific antigen (PSA) in men over 40
- Assessment of cardiovascular risk factors 2
Classification of Hypogonadism
- Primary hypogonadism: High LH/FSH with low testosterone (testicular failure)
- Secondary hypogonadism: Low/normal LH/FSH with low testosterone (pituitary/hypothalamic dysfunction) 1, 3
Evaluation for Underlying Causes
Medication review: Check for drugs that can cause hypogonadism:
- Opioids
- Estrogens
- Testosterone/androgenic anabolic steroids
- Glucocorticoids
- GnRH agonists/antagonists
- Verapamil
- Spironolactone 2
Metabolic assessment:
- BMI and waist circumference
- Screening for obesity, metabolic syndrome, diabetes 1
Rule out acute illness: Avoid testosterone testing during acute illness 1
Treatment Approaches
Primary Hypogonadism
Testosterone Replacement Therapy (TRT):
First-line options:
Target testosterone levels: 450-600 ng/dL (mid-normal range) 2
Dose adjustment guide:
Pre-Dose Morning Testosterone Dose Adjustment >750 ng/dL Decrease daily dose by 20-25% 350-750 ng/dL No change <350 ng/dL Increase daily dose by 20-25%
Secondary Hypogonadism with Fertility Concerns
Clomiphene citrate: Commonly prescribed off-label to preserve fertility 2
Gonadotropin therapy:
Lifestyle Interventions
- Weight loss through low-calorie diets can reverse obesity-associated secondary hypogonadism 1, 2
- Combining lifestyle changes with TRT may yield better outcomes in symptomatic patients 2
Monitoring and Safety
Follow-up Testing
- Testosterone levels: After starting treatment and every 6-12 months 2
- Hemoglobin/hematocrit: Discontinue treatment if Hct >54% 2
- PSA: Monitor according to guidelines; consider discontinuation if significant increase 2, 5
- Estradiol: Monitor for gynecomastia 2
Contraindications for TRT
Absolute contraindications:
- Prostate cancer
- Breast cancer
- Desire for near-term fertility
- Severe sleep apnea
- Uncontrolled heart failure
- Recent cardiovascular events 2
Relative contraindications:
- History of hepatocellular carcinoma
- Thrombosis
- Other cardiovascular risk factors 2
Potential Side Effects
- Erythrocytosis (dose-dependent: 2.8-17.9%)
- Suppression of spermatogenesis
- Peripheral edema
- Emotional lability
- Increased PSA (11.1% in clinical trials)
- Gynecomastia 2, 5
Special Considerations
- TRT should not be prescribed to men interested in current or future fertility 2
- Evaluate reproductive health if fertility is desired 2
- Consider testicular exam and serum FSH measurement in fertility assessment 2
Treatment Outcomes
- Improved sexual function and libido
- Small improvements in quality of life
- Potential improvements in bone mineral density and lean body mass
- Possible improvements in depressive symptoms 2